Dr. Kennedy qualified at Guy’s
Hospital, London, in 1984, having graduated from Keble
College, Oxford, with a degree in Experimental Psychology.
His training was obtained at the John Radcliffe Hospital,
Oxford; Queen Charlotte’s & Chelsea Hospital,
London, and the Royal Berkshire Hospital, Reading. In
1991, he was awarded the Royal College of Obstetricians
& Gynaecologists (RCOG) Thomas Eden Travelling Fellowship
and spent time as Visiting Assistant Professor at the
University of Texas Health Science Center, San Antonio.
He held the posts of Research Fellow
(1986-89), Clinical Lecturer (1992-94), and Senior Fellow
in Reproductive Medicine (1994-99) in the Nuffield Department
of Obstetrics & Gynaecology, University of Oxford,
before being appointed to the post of Clinical Reader
in 1999.
Dr Kennedy's research interests in
endometriosis include genetic epidemiology, health services
research, development of new diagnostic tests, and clinical
drug trials. He jointly heads an international research
group, which aims to identify the genes that predispose
women to develop endometriosis.
He is a medical adviser to the American
Endometriosis Association and a Trustee of the UK National
Endometriosis Society, both of which are national, patients’
self-help groups. He is also a medical adviser to Ferring,
Pfizer, Bayer Schering Pharma, TAP and Takeda. He is
a member of a working party of the UK All Party Parliamentary
Group on Endometriosis. He is the author of a number
of chapters and over 100 academic papers about endometriosis,
and has edited a book entitled ‘Chronic Pelvic
Pain’. He has prepared clinical guidelines for
the RCOG on the management of both chronic pelvic pain
and endometriosis, and he is a member of the working
party that wrote the ESHRE guideline for the diagnosis
and management of endometriosis.
Dr Kennedy is a founding board member
of the World Endometriosis Research Foundation and acts
as its secretary and treasurer.
.gif)
